ÂÜÀòÂÒÂ×

John J. Kaiser possesses extensive experience in the biopharmaceutical and healthcare sectors, currently serving as Executive Chairman and Member of the Board of Directors at Evecxia Therapeutics, Inc. since March 2018. Previous leadership roles include CEO at Cerecor Inc. from October 2012 to December 2017, and Founder & CEO of Denysias Biosciences, LLC from October 2010 to September 2012. John also held the position of President at Kaiser & Associates Consulting, LLC for part of 2010 to 2012, and was VP of Commercial & Corporate Development at ACADIA Pharmaceuticals from February 2008 to January 2010. John’s career began at Eli Lilly and Company, where a focus on general management, marketing, and sales spanned 28 years. Academic credentials include a Bachelor of Pharmacy from the University of Cincinnati, with studies completed from 1974 to 1979.